» Articles » PMID: 37508526

ROP16 of Inhibits Innate Immunity by Triggering CGAS-STING Pathway Inactivity Through the Polyubiquitination of STING

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 29
PMID 37508526
Authors
Affiliations
Soon will be listed here.
Abstract

cGAS-STING signaling is a major pathway in inducing type Ⅰ IFN, which plays a crucial role in the defense against infection. In contrast, develops multiple strategies to counteract the host defense, causing serious diseases in a wide range of hosts. Here, we demonstrate that rhoptry protein 16 (ROP16) dampens type I interferon signaling via the inhibition of the cGAS (cyclic GMP-AMP synthase) pathway through the polyubiquitination of STING. Mechanistically, ROP16 interacts with STING through the SignalP domain and inhibits the K63-linked ubiquitination of STING in an NLS (nuclear localization signal)-domain-dependent manner. Consequently, knocking out the ROP16 in PRU tachyzoites promotes the STING-mediated production of type I IFNs and limits the replication of Together, these findings describe a distinct pathway where exploits the ubiquitination of STING to evade host anti-parasite immunity, revealing new insights into the interaction between the host and parasites.

Citing Articles

Transcriptional profiles analysis of effects of rhoptry protein 16 on THP-1 macrophages.

Yang N, Li M, Yang H, Li J, Dang T, Li G Front Cell Infect Microbiol. 2025; 14:1436712.

PMID: 39935538 PMC: 11810957. DOI: 10.3389/fcimb.2024.1436712.


Vaccination with a DNA vaccine cocktail encoding TgROP2, TgROP5, TgROP9, TgROP16, TgROP17, and TgROP18 confers limited protection against Toxoplasma gondii in BALB/c mice.

Du R, He J, Meng J, Zhang D, Li D, Wang H Parasitol Res. 2024; 123(12):420.

PMID: 39724445 DOI: 10.1007/s00436-024-08435-3.


ROP5 Enhances Type I IFN Responses by Promoting Ubiquitination of STING.

Jin Q, Yu T, Pan M, Fan Y, Ge C, He X Int J Mol Sci. 2024; 25(20).

PMID: 39457045 PMC: 11508707. DOI: 10.3390/ijms252011262.


Mutual regulations between and type I interferon.

Song L, Wang R, Cao Y, Yu L Front Immunol. 2024; 15:1428232.

PMID: 39040112 PMC: 11260619. DOI: 10.3389/fimmu.2024.1428232.


Toxoplasma gondii suppresses proliferation and migration of breast cancer cells by regulating their transcriptome.

Ye H, Zhou X, Zhu B, Xiong T, Huang W, He F Cancer Cell Int. 2024; 24(1):144.

PMID: 38654350 PMC: 11040860. DOI: 10.1186/s12935-024-03333-1.

References
1.
Saeij J, Coller S, Boyle J, Jerome M, WHITE M, Boothroyd J . Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature. 2006; 445(7125):324-7. PMC: 2637441. DOI: 10.1038/nature05395. View

2.
Ihara F, Fereig R, Himori Y, Kameyama K, Umeda K, Tanaka S . Dense Granule Proteins 7, 14, and 15 Are Involved in Modification and Control of the Immune Response Mediated via NF-κB Pathway. Front Immunol. 2020; 11:1709. PMC: 7412995. DOI: 10.3389/fimmu.2020.01709. View

3.
Shastri A, Marino N, Franco M, Lodoen M, Boothroyd J . GRA25 is a novel virulence factor of Toxoplasma gondii and influences the host immune response. Infect Immun. 2014; 82(6):2595-605. PMC: 4019154. DOI: 10.1128/IAI.01339-13. View

4.
Pierog P, Zhao Y, Singh S, Dai J, Yap G, Fitzgerald-Bocarsly P . Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10. J Immunol. 2017; 200(1):186-195. PMC: 7441501. DOI: 10.4049/jimmunol.1701045. View

5.
Pifer R, Yarovinsky F . Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 2011; 27(9):388-93. PMC: 3159709. DOI: 10.1016/j.pt.2011.03.009. View